Correlation Between Anika Therapeutics and Pulmonx Corp
Can any of the company-specific risk be diversified away by investing in both Anika Therapeutics and Pulmonx Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anika Therapeutics and Pulmonx Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anika Therapeutics and Pulmonx Corp, you can compare the effects of market volatilities on Anika Therapeutics and Pulmonx Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anika Therapeutics with a short position of Pulmonx Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anika Therapeutics and Pulmonx Corp.
Diversification Opportunities for Anika Therapeutics and Pulmonx Corp
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Anika and Pulmonx is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Anika Therapeutics and Pulmonx Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmonx Corp and Anika Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anika Therapeutics are associated (or correlated) with Pulmonx Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmonx Corp has no effect on the direction of Anika Therapeutics i.e., Anika Therapeutics and Pulmonx Corp go up and down completely randomly.
Pair Corralation between Anika Therapeutics and Pulmonx Corp
Given the investment horizon of 90 days Anika Therapeutics is expected to under-perform the Pulmonx Corp. In addition to that, Anika Therapeutics is 1.34 times more volatile than Pulmonx Corp. It trades about -0.18 of its total potential returns per unit of risk. Pulmonx Corp is currently generating about 0.06 per unit of volatility. If you would invest 613.00 in Pulmonx Corp on August 24, 2024 and sell it today you would earn a total of 29.00 from holding Pulmonx Corp or generate 4.73% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anika Therapeutics vs. Pulmonx Corp
Performance |
| Timeline |
| Anika Therapeutics |
| Pulmonx Corp |
Anika Therapeutics and Pulmonx Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anika Therapeutics and Pulmonx Corp
The main advantage of trading using opposite Anika Therapeutics and Pulmonx Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anika Therapeutics position performs unexpectedly, Pulmonx Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmonx Corp will offset losses from the drop in Pulmonx Corp's long position.| Anika Therapeutics vs. Axogen Inc | Anika Therapeutics vs. Orthofix Medical | Anika Therapeutics vs. SurModics | Anika Therapeutics vs. Paragon 28 |
| Pulmonx Corp vs. Iradimed Co | Pulmonx Corp vs. Orthofix Medical | Pulmonx Corp vs. Neuropace | Pulmonx Corp vs. Integer Holdings Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |